Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

    Grant supports developing assays to find new therapies for brain and muscle diseases within IGNITE program; doesn't fund clinical trials.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

    Funding support available to study and prove effectiveness of potential neurotherapeutic agents for neurological disorders towards further development.

    HHS-NIH11Due Feb 18, 2027

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

    This grant supports creating and validating animal models and tissue systems mimicking neurological disorders to advance neurotherapeutic discovery.

    HHS-NIH11Due Feb 18, 2027$750,000

    Translational Neural Devices (R61/R33 - Clinical Trial Optional)

    Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.

    HHS-NIH11Due Jan 28, 2027

    NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)

    Grant supports translation of basic research into clinical tools improving human health by encouraging collaboration between scientists and clinicians for communication disorder research.

    HHS-NIH11Due Jan 13, 2027$500,000

    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)

    NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.

    HHS-NIH11Due Feb 16, 2027$275,000